Global Pharyngitis Treatment Market Growth Accelerates: Strategic Forecast Predicts $3 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Pharyngitis Treatment Industry Market Size Be by 2025?
The pharyngitis treatment market has shown consistent growth in recent years. It is projected to increase from $2.27 billion in 2024 to $2.37 billion in 2025, registering a compound annual growth rate (CAGR) of 4.2%. The expansion during the historic period can be linked to factors such as the rising prevalence of flu and pharyngitis, heightened public awareness, improved access to healthcare services, and growing disposable incomes.

What's the Long-Term Growth Forecast for the Pharyngitis Treatment Market Size Through 2029?
Anticipating substantial expansion in the upcoming years, the market dedicated to pharyngitis treatment is projected to attain a valuation of $3 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.1%. This upward trajectory throughout the projection timeframe is fueled by several factors, including the increasing utilization of rapid point-of-care diagnostic tools, a growing need for tailored medical approaches, the widespread issue of antibiotic resistance, and the heightened recognition of the necessity of proper hand hygiene practices. Key developments shaping the market during this period are anticipated to involve progress in the research and development efforts for novel pharyngitis treatments, the integration of digital health solutions, and the broader adoption of telehealth services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Pharyngitis Treatment Market Expansion?
The rising spread of strep throat is anticipated to fuel the growth of the pharyngitis treatment market in the coming years. Strep throat is a contagious bacterial infection that mainly impacts the throat and tonsils. Timely and proper antibiotic treatment helps relieve symptoms, prevent complications, and limit the infection's transmission. For instance, in June 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, around 14,000 to 25,000 cases of invasive group A strep disease occur annually in the United States. Moreover, strep diseases account for approximately 5.2 million outpatient visits and 2.8 million antibiotic prescriptions each year. Hence, the increasing transmission of strep throat is driving the growth of the pharyngitis treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp

What Are the Key Trends Driving Pharyngitis Treatment Market Growth?
Leading entities within the pharyngitis remedy sector are concentrating efforts on pioneering solutions, particularly oral single-drug treatments, aiming to boost patient adherence while delivering therapeutic approaches that are both efficacious and user-friendly. Oral monotherapy concept signifies the application of just one prescribed agent or medicinal substance taken by mouth to manage a particular ailment or sickness, distinguishing itself through the deployment of a solitary therapeutic component rather than a regimen combining various interventions to attain the intended medical outcome. As a relevant parallel, in the closing month of 2023, Novartis AG, a global pharmaceutical giant headquartered in Switzerland, secured clearance from the FDA for Fabhalta (iptacopan), marking its status as the inaugural oral monotherapy specifically designated for adults afflicted with paroxysmal nocturnal hemoglobinuria ($text{PNH}$), a pivotal accomplishment reached on [date] that signifies substantial progress by introducing a novel treatment modality capable of elevating hemoglobin metrics, thereby removing reliance on recurrent blood transfusions.

How Is the Pharyngitis Treatment Market Segmented?
The pharyngitis treatmentmarket covered in this report is segmented -

1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
2) By Source of Infection: Viral; Bacterial
3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users

Subsegments:
1) By Beta Lactams: Penicillins; Amoxicillin; Ampicillin
2) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
3) By Cephalosporins: Cefuroxime; Ceftriaxone; Cefdinir
4) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin
5) By Tetracycline: Doxycycline; Minocycline; Tetracycline
6) By Other Drug Classes: Clindamycin; Sulfonamides; Carbapenems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp

Which Companies Are Leading the Charge in Pharyngitis Treatment Market Innovation?
Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

Which Regions Are Leading the Global Pharyngitis Treatment Market in Revenue?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12937

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.